CSTF logo

CuraScientific Corp (CSTF) Aktienanalyse

Nur zu Informationszwecken. Keine Finanzberatung. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Mit einem Kurs von $ ist CuraScientific Corp (CSTF) ein Healthcare-Unternehmen mit einer Bewertung von 0. Bewertet mit 42/100 (vorsichtig) bei Wachstumspotenzial, finanzieller Gesundheit und Momentum.

Zuletzt analysiert: 15. März 2026
42/100 KI-Bewertung

CuraScientific Corp (CSTF) Gesundheitswesen & Pipeline-Uebersicht

CEOSamuel L. Berry
Mitarbeiter2
HauptsitzCoachella, US
IPO-Jahr1998

CuraScientific Corp. (CSTF) is a manufacturer and distributor of cannabis, cannabidiol, kava, and kratom products, operating under the JW Brands and Chad Enterprises brands. Formerly Boon Industries, the company focuses on the specialty and generic drug market, based in Coachella, California.

Datenherkunft | Finanzdaten Quantitative Analyse NASDAQ Analyse: 15. März 2026

Investmentthese

Investing in CuraScientific Corp. (CSTF) presents a high-risk, high-reward scenario. The company's negative profit margin of -15299.2% and gross margin of -3298.1% indicate significant financial challenges. Growth catalysts include potential expansion of its product line and market reach within the cannabis and nutraceutical sectors. However, the company's small size (2 employees) and OTC market listing introduce substantial risks related to liquidity and regulatory compliance. The negative beta of -4.74 suggests an inverse correlation with the market, which could be a factor during market downturns. Investors should carefully consider the speculative nature of this investment, given the company's current financial performance and operational scale.

Basierend auf FMP-Finanzdaten und quantitativer Analyse

Wichtige Highlights

  • Market capitalization of $0.00B indicates a micro-cap company with limited financial resources.
  • Negative P/E ratio of -0.00 reflects the company's current lack of profitability.
  • Profit margin of -15299.2% highlights significant operational inefficiencies and cost management issues.
  • Gross margin of -3298.1% suggests that the company's cost of goods sold far exceeds its revenue, indicating fundamental problems with its business model.
  • Beta of -4.74 indicates an inverse correlation with the market, which could offer diversification benefits but also reflects the company's unique risk profile.

Wettbewerber & Vergleichsunternehmen

Staerken

  • Established brands (JW Brands and Chad Enterprises).
  • Diverse product offerings (cannabis, CBD, kava, kratom).
  • Early mover advantage in emerging markets.

Schwaechen

  • Limited financial resources.
  • Small operational scale (2 employees).
  • Negative profit and gross margins.
  • OTC market listing.

Katalysatoren

  • Upcoming: Potential changes in cannabis regulations at the state or federal level could create new market opportunities.
  • Ongoing: Increasing consumer demand for cannabis and related products is driving market growth.
  • Ongoing: Expansion of the company's product line and distribution network could lead to increased revenue.

Risiken

  • Potential: Intense competition from larger and more established companies.
  • Potential: Evolving regulatory landscape could create compliance challenges and increase costs.
  • Ongoing: Limited financial resources and small operational scale could hinder growth.
  • Ongoing: Negative profit and gross margins raise concerns about the company's financial sustainability.
  • Ongoing: OTC market listing introduces risks related to liquidity and transparency.

Wachstumschancen

  • Expansion into New Product Lines: CuraScientific Corp. can explore developing and launching new cannabis-related products, such as edibles, concentrates, and topicals, to cater to a broader customer base. The global cannabis market is projected to reach $90.4 billion by 2026, presenting significant revenue opportunities. This expansion requires investment in research and development, as well as compliance with regulatory standards. Timeline: 12-24 months.
  • Geographic Market Expansion: The company can expand its distribution network to new states and regions where cannabis is legal, increasing its market reach and revenue potential. The U.S. cannabis market alone is expected to reach $43 billion by 2025. This expansion requires navigating varying state regulations and establishing partnerships with local distributors. Timeline: 18-36 months.
  • Strategic Partnerships and Acquisitions: CuraScientific Corp. can pursue strategic partnerships or acquisitions to enhance its product portfolio, expand its market access, and gain economies of scale. The fragmented cannabis market offers opportunities for consolidation. This strategy requires careful due diligence and integration planning. Timeline: 24-48 months.
  • Development of Proprietary Formulations: Investing in research and development to create proprietary cannabis formulations with unique health benefits can provide a competitive advantage and attract a loyal customer base. The market for innovative cannabis products is growing rapidly. This requires investment in scientific research and intellectual property protection. Timeline: 36-60 months.
  • Focus on E-commerce and Direct-to-Consumer Sales: Establishing a strong online presence and direct-to-consumer sales channel can improve margins and enhance customer engagement. The e-commerce market for cannabis products is expanding rapidly. This requires investment in website development, digital marketing, and logistics infrastructure. Timeline: 12-24 months.

Chancen

  • Expansion into new product lines.
  • Geographic market expansion.
  • Strategic partnerships and acquisitions.
  • Development of proprietary formulations.

Risiken

  • Intense competition.
  • Evolving regulatory landscape.
  • Changing consumer preferences.
  • Limited access to capital.

Wettbewerbsvorteile

  • Brand recognition through JW Brands and Chad Enterprises (limited evidence of brand strength).
  • Proprietary formulations (if any).
  • Distribution network (limited information available).

Ueber CSTF

CuraScientific Corp., formerly known as Boon Industries, was incorporated in 2020 and rebranded in April 2023. The company is involved in the manufacturing, distribution, and sale of cannabis products, cannabidiol (CBD), kava, and kratom. These products are marketed under the JW Brands and Chad Enterprises brand names. Based in Coachella, California, CuraScientific Corp. operates within the specialty and generic drug manufacturing industry. The company's business model focuses on catering to the growing market for alternative wellness products. It aims to establish a presence in the competitive cannabis and related products market through its branded offerings. CuraScientific Corp. faces the challenges of navigating the complex regulatory landscape and intense competition within the cannabis and nutraceutical sectors. The company's success will depend on its ability to effectively market its products, maintain quality control, and adapt to changing consumer preferences and regulatory requirements.

Was das Unternehmen tut

  • Manufactures cannabis products.
  • Distributes cannabis products.
  • Sells cannabis products under the JW Brands brand.
  • Sells cannabis products under the Chad Enterprises brand.
  • Offers cannabidiol (CBD) products.
  • Offers kava products.
  • Offers kratom products.

Geschaeftsmodell

  • Manufactures cannabis, CBD, kava, and kratom products.
  • Distributes products through various channels.
  • Generates revenue through the sale of branded products.

Branchenkontext

CuraScientific Corp. operates in the Drug Manufacturers - Specialty & Generic industry, which is experiencing growth driven by increasing demand for cannabis and related products. The market is characterized by intense competition and evolving regulatory landscapes. Companies like GRVE and CNNXF are also active in this space. CuraScientific Corp. faces the challenge of differentiating itself and establishing a sustainable market position. The industry is subject to changing consumer preferences and regulatory requirements, requiring companies to be agile and innovative.

Wichtige Kunden

  • Consumers seeking cannabis products.
  • Consumers seeking cannabidiol (CBD) products.
  • Consumers seeking kava products.
  • Consumers seeking kratom products.
KI-Zuversicht: 69% Aktualisiert: 15. März 2026

Finanzdaten

Chart & Info

CuraScientific Corp (CSTF) Aktienkurs: Price data unavailable

Aktuelle Nachrichten

Keine aktuellen Nachrichten fuer CSTF verfuegbar.

Analystenkonsens

Konsens-Bewertung

Aggregierte Kauf-/Halten-/Verkauf-Empfehlungen von Benzinga, Yahoo Finance und Finnhub fuer CSTF.

Kursziele

Wall-Street-Kurszielanalyse fuer CSTF.

MoonshotScore

42/100

Was bedeutet diese Bewertung?

Der MoonshotScore bewertet das Wachstumspotenzial von CSTF auf einer Skala von 0-100 ueber mehrere Faktoren wie Innovation, Marktdisruption, finanzielle Gesundheit und Momentum.

Fuehrung: Samuel L. Berry

Managing Employee

Samuel L. Berry is currently the managing employee of CuraScientific Corp. His background and experience prior to joining CuraScientific Corp. are not detailed in the provided data. As the managing employee, he is responsible for overseeing the company's operations and strategy.

Erfolgsbilanz: Due to the limited information available, it is not possible to assess Samuel L. Berry's track record at CuraScientific Corp. or any previous roles. The company's performance metrics, such as negative profit and gross margins, suggest significant challenges during his tenure.

CSTF OTC-Marktinformationen

The OTC Other tier represents the lowest tier of the OTC market, indicating that CuraScientific Corp. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier often have limited trading volume and higher price volatility compared to those listed on major exchanges like NYSE or NASDAQ. Investing in OTC Other stocks carries significant risks due to the lack of regulatory oversight and transparency.

  • OTC-Stufe: OTC Other
  • Offenlegungsstatus: Unknown
Liquiditaet: Liquidity for CSTF is likely very limited, given its OTC Other listing and market capitalization of $0.00B. This could result in wide bid-ask spreads and difficulty in buying or selling shares without significantly impacting the price. Investors should be prepared for potential illiquidity and price volatility.
OTC-Risikofaktoren:
  • Limited financial disclosure.
  • Low trading volume and liquidity.
  • Higher price volatility.
  • Potential for fraud or manipulation.
  • Lack of regulatory oversight.
Sorgfaltspruefung-Checkliste:
  • Verify the company's registration and legal status.
  • Obtain and review available financial statements.
  • Assess the company's business model and competitive landscape.
  • Evaluate the management team's experience and track record.
  • Understand the risks associated with the OTC market.
  • Consult with a qualified financial advisor.
  • Check for any regulatory actions or legal disputes.
Legitimitaetssignale:
  • Company has a registered business address.
  • Company has a website and contact information.
  • Company has been in operation since 2020.
  • Company rebranded in April 2023, indicating ongoing operations.
  • Company offers specific products (cannabis, CBD, kava, kratom).

Haeufige Fragen zu CSTF

What are the key factors to evaluate for CSTF?

CuraScientific Corp (CSTF) currently holds an AI score of 42/100, indicating low score. Key strength: Established brands (JW Brands and Chad Enterprises).. Primary risk to monitor: Potential: Intense competition from larger and more established companies.. This is not financial advice.

How frequently does CSTF data refresh on this page?

CSTF prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.

What has driven CSTF's recent stock price performance?

Recent price movement in CuraScientific Corp (CSTF) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Established brands (JW Brands and Chad Enterprises).. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.

Should investors consider CSTF overvalued or undervalued right now?

Determining whether CuraScientific Corp (CSTF) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.

What research should beginners do before buying CSTF?

Before investing in CuraScientific Corp (CSTF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Why might investors consider adding CSTF to a portfolio?

Potential reasons to consider CuraScientific Corp (CSTF) depend on individual investment goals and risk tolerance. A key strength identified by analysis: Established brands (JW Brands and Chad Enterprises).. Additionally: Diverse product offerings (cannabis, CBD, kava, kratom).. Always weigh potential rewards against risks and diversify across holdings. This is not financial advice.

Can I buy fractional shares of CSTF?

Yes, most major brokerages offer fractional shares of CuraScientific Corp (CSTF) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.

How can I track CSTF's earnings and financial reports?

CuraScientific Corp (CSTF) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Setting up alerts through your brokerage for CSTF earnings announcements is recommended.

Haftungsausschluss: Dieser Inhalt dient ausschliesslich zu Informationszwecken und stellt keine Anlageberatung dar. Fuehren Sie immer Ihre eigene Recherche durch und konsultieren Sie einen Finanzberater.

Offizielle Ressourcen

Analyse aktualisiert am KI-Bewertung taeglich aktualisiert
Datenquellen & Methodik
Marktdaten bereitgestellt von Financial Modeling Prep & Yahoo Finance. KI-Analyse durch proprietaere Algorithmen von Stock Expert AI. Technische Indikatoren nach branchenueblichen Berechnungsstandards. Zuletzt aktualisiert: .

Daten dienen ausschliesslich zu Informationszwecken.

Analysehinweise
  • Limited information available on the company's financials and operations.
  • OTC market listing introduces additional risks and uncertainties.
  • AI analysis pending for CSTF.
Datenquellen

Popular Stocks